NNC0215-0384

· Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NNC0215-0384, covering 2014-10-15 to 2017-02-27. Get the full timeline:

Most recent: Clinical Trial Update: First Human Dose Trial of NNC0215-0384 in Subjects With Rheumatoid Arthritis [Phase 1]